(Q45372857)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

María Carmen Cenit

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Koen Vandenbroeck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Roberto Alvarez-Lafuente

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Elena Urcelay

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

I Alloza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

B Swaminathan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

A Antigüedad

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J Olascoaga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M G Barcina

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

V de las Heras

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Bartolomé

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Fernández-Arquero

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

R Arroyo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

23 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

40-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gene.2010.46

14 February 2020

exact match

0 references

cites work

The IRF family transcription factors in immunity and oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Triggering the innate antiviral response through IRF-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Association of an IRF5 gene functional polymorphism with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Risk alleles for multiple sclerosis identified by a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Pharmacogenomics of IFN-beta in multiple sclerosis: towards a personalized medicine approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Targeting signal transduction as a strategy to treat inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Use of lyophilized standards for the calibration of a newly developed real time PCR assay for human herpes type six (HHV6) variants A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Analysis ofIRF5 gene functional polymorphisms in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

Human Herpesvirus 6A DNA Is Detected Frequently in Plasma but Rarely in Peripheral Blood Leukocytes of Patients after Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

inferred from DOI database lookup

7 January 2021

based on heuristic

Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2010.46

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GENE.2010.46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20861862%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

14 February 2020

1015612682

0 references

1 reference